TuesdayJul 28, 2020 12:45 pm

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces Scheduled Release of Q2 2020 Results, Conference Call

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) on Monday announced that it will release its second quarter 2020 results after the close of markets on Friday, August 14, 2020. According to the update, senior management will host a conference call to discuss the results at 11 a.m. ET on Monday, August 17, 2020. Interested parties may join the call by dialing 647-427-7450 or 1-888-231-8191 and entering conference ID: 8762205. Participants may register for and log into the live webcast at http://ibn.fm/KcLod. The webcast will be archived for 90 days. To view the full press release, visit http://ibn.fm/2MgCw About VIVO Cannabis(TM) VIVO…

Continue Reading

MondayJul 06, 2020 11:09 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Issues Update on Global Medical Business

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc. ("ABcann") and Harvest Medicine Inc. ("Harvest Medicine"), today provided an update on its global medical business, which operates in Canada, Germany and Australia. "One of our top strategic priorities is to focus on the global medical cannabis market, directly servicing tens of thousands of patients and investing in product development initiatives that prioritize high-quality novel products," Barry Fishman, CEO of VIVO, stated in the news…

Continue Reading

MondayJun 29, 2020 10:08 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Issues Update on Adult-Use Products

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited, ABcann Medicinals Inc. and Harvest Medicine Inc., today provided an update on its adult-use cannabis products. According to the update, VIVO recently made initial shipments of its Fireside X shatter product to several provincial wholesalers, representing its second significant concentrates product format launch with an expected significant contribution to the Company's revenue. "I am pleased to announce that our early shatter sales have exceeded our expectations. We have shipped to…

Continue Reading

WednesdayJun 24, 2020 10:32 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Enters Supply and Clinic Services Agreements with Medical Cannabis by Shoppers(TM)

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) and its subsidiaries have entered into both a product supply agreement and a clinic services agreement with Medical Cannabis by Shoppers(TM). Under the supply agreement, VIVO’s licensed producers will offer a broad portfolio of Canna Farms(TM) and Beacon Medical(TM) branded medical cannabis products through the Medical Cannabis by Shoppers(TM) online sales platform, accessible to patients across Canada. "We have a six-year track record of cultivating and producing high-quality, medical-grade cannabis and are thrilled to partner with Shoppers Drug Mart Inc." Barry Fishman, CEO of VIVO, said in the news release. "VIVO is extremely committed…

Continue Reading

MondayJun 22, 2020 10:20 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces Expansion of Cultivation and Processing Capacity

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that its wholly-owned subsidiary, Canna Farms Limited, has received all necessary Health Canada approvals to commence operations in its Phase 5 expansion, and that its wholly-owned subsidiary, ABcann Medicinals Inc. ("NCC"), has begun commercial production in its ethanol extraction suite. According to the update, the Phase 5 expansion of the Hope, British Columbia facility consists of 10,000 square feet of production space customized to incorporate Canna Farms' two-tier growing systems, as well as vegetative, mother and processing rooms and storage vaults. "Health Canada's approval of Phase 5 is a major milestone for…

Continue Reading

FridayJun 19, 2020 12:17 pm

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Partners with Medipharm Labs to Leverage GMP Production Capabilities, Accelerate Australian Market Presence

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that its subsidiary, Beacon Medical Australia Pty. Ltd. ("Beacon Medical Australia"), entered into an agreement with MediPharm Labs Australia Pty. Ltd. ("MediPharm Labs Australia"), a subsidiary of MediPharm Labs Corp. (TSX: LABS) ("MediPharm Labs"). Under the agreement, MediPharm Labs Australia will supply pharmaceutical-quality (GMP certified), formulated cannabis oil products to Beacon Medical Australia to sell into the Australian market. "VIVO's international efforts remain focused on the emerging Australian and German markets and we continue to seek out partnerships with organizations that have proven track records," Barry Fishman, CEO of VIVO, said in…

Continue Reading

FridayMay 29, 2020 11:22 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces AGM 2020 Results, Election of New Director

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) on Thursday announced the election of each of the seven individuals nominated as a director of VIVO at the company's Annual General and Special Meeting of Shareholders held on May 28, 2020. According to the update, VIVO management nominated each of the existing directors, together with new nominee, Christie Henderson, for election at the meeting. Henderson is the managing partner and CEO of Henderson Partners LLP, a firm of chartered professional accountants and advisors, as well as a certified corporate director (“ICD.D”). She has more than 20 years of experience with consumer products, retail,…

Continue Reading

FridayMay 15, 2020 10:25 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces Results for Q1 2020

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) on Thursday released its first quarter 2020 financial and operating results. Among the highlights, the company reported an increase in net revenue to $8.2 million. “Our positive first quarter 2020 results were fueled by a net revenue increase of 24% compared with the previous quarter,” VIVO CEO Barry Fishman said in the news release. “Several of our Canna Farms(TM) and Fireside(TM) cannabis 2.0 products are showing strong momentum, and the VIVO team continued to execute well on plans related to our four strategic priorities, despite COVID-19 related challenges. In April, we started planting in…

Continue Reading

MondayMay 11, 2020 11:18 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) to Release and Host Conference Call for Q1 2020 Results

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that it will release its first quarter 2020 results after the close of markets on Thursday, May 14, 2020. In addition, VIVO Cannabis’ senior management will host a conference call at 10 a.m. ET on Friday, May 15, 2020, to discuss the results. Interested parties may join the call by dialing 647-427-7450 or 1-888-231-8191 and entering conference ID: 8835659. The live webcast may be accessed by visiting http://ibn.fm/fn65r and will be archived for 90 days. To view the full press release, visit http://ibn.fm/cAlyo About VIVO Cannabis(TM) VIVO Cannabis(TM) is recognized for trusted,…

Continue Reading

FridayApr 03, 2020 11:54 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces Partial Debenture Repurchase

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that it has re-purchased for cancellation certain of its outstanding 6% unsecured convertible debentures in the aggregate principal amount of $10 million, for a purchase price of $9.3 million (plus accrued and unpaid interest thereon), representing a 7% discount to the face value, pursuant to an agreement with the holder thereof. The company, as a result of the repurchase, now has Debentures in the aggregate principal amount of $24.5 million due February 28, 2021. “As evidenced by our recent financial results, VIVO continues to enjoy a strong cash position,” VIVO's Chief Executive…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered